Market Overview   The Neurodegenerative Disease Therapeutics Market was valued at US$ 12.52 billion in 2024 and is projected to reach US$ 28.78 billion by 2033, registering a CAGR of 9.8% throughout the forecast period 2025 to 2033. The Neurodegenerative Disease Therapeutics Market is surging with rising approvals for drugs targeting Alzheimer's, Parkinson's, and ALS. Aging populations...